Author

A.-M. Turner

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:ATAC-seq· 1 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:drug response / drug discovery· 1 Assay:proteomics· 1

Frequent Co-Authors

L. I. James· 2 shared D. M. Margolis· 1 shared D. Margolis· 1 shared E. P. Browne· 1 shared F. Potjewyd· 1 shared J. Beri· 1 shared J. Norris-Drouin· 1 shared J. Parker· 1 shared

Activity by Year

2019-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

L. I. James

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Epigenomic characterization of latent HIV infection identifies latency regulating transcription factors.

S. R. Jefferys, S. D. Burgos, J. Peterson, S. R. Selitsky, A.-M. Turner, L. I. James, D. M. Margolis, J. Parker, E. P. Browne

This study identifies transcription factors regulating HIV latency through epigenomic analysis of latently infected cells.

PLOS Pathogens · Feb 26, 2021Peer-reviewedMicrobiology

Degradation of Polycomb Repressive Complex 2 with an EED-targeted Bivalent Chemical Degrader

F. Potjewyd, A.-M. Turner, J. Beri, J. Rectenwald, J. Norris-Drouin, S. Cholensky, D. Margolis, K. Pearce, L. Herring, L. I. James

This paper introduces a bivalent chemical degrader, UNC6852, that targets PRC2 components and demonstrates its ability to degrade PRC2 and inhibit EZH2 activity in cancer cells.

bioRxiv · Jun 21, 2019Cancer Biology